Bank Of America Corp Vertex Pharmaceuticals Inc Transaction History

Bank Of America Corp

$1.21 Trillion
Q1 2025

A detailed history of Bank Of America Corp transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Bank Of America Corp holds 2,864,998 shares of VRTX stock, worth $1.28 Billion. This represents 0.11% of its overall portfolio holdings.

Number of Shares

2,864,998

Previous 2,419,353 18.42%

Holding current value

$1.28 Billion

Previous $974 Million 42.57%

% of portfolio

0.11%

Previous 0.08%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$402.49 - $513.76 $179 Million - $229 Million	445,645 Added 18.42%	2,864,998 $1.39 Billion
Q4 2024 Feb 14, 2025	SELL	$396.64 - $516.74 $75.2 Million - $98 Million	-189,604 Reduced 7.27%	2,419,353 $974 Million
Q3 2024 Nov 14, 2024	BUY	$460.0 - $505.78 $16.8 Million - $18.4 Million	36,472 Added 1.42%	2,608,957 $1.21 Billion
Q2 2024 Aug 14, 2024	BUY	$392.81 - $485.53 $10.9 Million - $13.5 Million	27,847 Added 1.09%	2,572,485 $1.21 Billion
Q1 2024 May 15, 2024	BUY	$407.69 - $446.08 $44.3 Million - $48.5 Million	108,718 Added 4.46%	2,544,638 $1.06 Billion
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $32.9 Million - $39.4 Million	95,845 Added 4.1%	2,435,920 $991 Million
Q2 2023 Aug 14, 2023	SELL	$314.42 - $351.91 $77.1 Million - $86.2 Million	-245,069 Reduced 9.48%	2,340,075 $823 Million
Q1 2023 May 12, 2023	BUY	$283.23 - $323.1 $24.9 Million - $28.5 Million	88,084 Added 3.53%	2,585,144 $815 Million
Q4 2022 Feb 10, 2023	SELL	$285.76 - $321.48 $8.69 Million - $9.77 Million	-30,395 Reduced 1.2%	2,497,060 $721 Million
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $46.4 Million - $51.7 Million	-169,343 Reduced 6.28%	2,527,455 $732 Million
Q2 2022 Aug 12, 2022	SELL	$234.96 - $292.55 $99.1 Million - $123 Million	-421,749 Reduced 13.52%	2,696,798 $760 Million
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $4.55 Million - $5.36 Million	20,530 Added 0.66%	3,118,547 $814 Million
Q4 2021 Feb 08, 2022	BUY	$177.01 - $223.45 $12 Million - $15.1 Million	67,661 Added 2.23%	3,098,017 $680 Million
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $272 Million - $304 Million	1,497,012 Added 97.63%	3,030,356 $550 Million
Q2 2021 Sep 13, 2021	BUY	$187.49 - $221.1 $287 Million - $339 Million	1,533,344 New	1,533,344 $309 Million

Others Institutions Holding VRTX

# of Institutions

1,832

Shares Held

233M

Call Options Held

1.38M

Put Options Held

1.08M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $115B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Vertex Pharmaceuticals Inc Transaction History